Letter to Editor on 'A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India'

• Bharat Krushna Khuntia,
• Aman Agarwal,
• Gautam Sharma

Affiliations

Bharat Krushna Khuntia

Centre for Integrative Medicine and Research (CIMR), All India Institute of Medical Sciences, New Delhi, India

Aman Agarwal

Centre for Integrative Medicine and Research (CIMR), All India Institute of Medical Sciences, New Delhi, India

Gautam Sharma

Correspondence to: Department of Cardiology, Centre for Integrative Medicine and Research, All India Institute of Medical Sciences, New Delhi, India.; Centre for Integrative Medicine and Research (CIMR), All India Institute of Medical Sciences, New Delhi, India